Your Article Summary
Systemic Therapies in Hepatocellular Carcinoma
Digestive Diseases, 06/24/09
Worns MA et al. - The article reviews the historical perspective of systemic therapy in HCC and provides a brief overview of molecular hepatocarcinogenesis and potential targets in HCC. Most promising molecular targeted agents tested within clinical trials in advanced HCC are summarized, with a special attention to sorafenib, sunitinib, bevacizumab, and erlotinib.
Related Articles
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09
Relevance Score: 69%
Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09
Relevance Score: 69%
Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09
Relevance Score: 68%
Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09
Relevance Score: 68%
MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09
Relevance Score: 68%
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients
Scandinavian Journal of Pain, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Resveratrol (trans-3, 5, 4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-kB activation to abrogate DSS-induced colitis
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult
Annals of Pharmacotherapy, 12/03/09

See Latest Articles